DE60322871D1 - THINKING PREPARATIONS - Google Patents
THINKING PREPARATIONSInfo
- Publication number
- DE60322871D1 DE60322871D1 DE60322871T DE60322871T DE60322871D1 DE 60322871 D1 DE60322871 D1 DE 60322871D1 DE 60322871 T DE60322871 T DE 60322871T DE 60322871 T DE60322871 T DE 60322871T DE 60322871 D1 DE60322871 D1 DE 60322871D1
- Authority
- DE
- Germany
- Prior art keywords
- thinking
- preparations
- adhyperforin
- hyperforin
- alzheimer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/713—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
- C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
- C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/46—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing nine carbon atoms
Abstract
The use of the reduction products of hyperforin and adhyperforin, pharmaceutically acceptable salts or esters thereof, in the pharmaceutical and/or nutritional field, in particular in the treatment of depression and Alzheimer's disease.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002MI000872A ITMI20020872A1 (en) | 2002-04-23 | 2002-04-23 | HYPERPHORINE DERIVATIVES THEIR USE AND FORMULATIONS CONTAINING THEM |
PCT/EP2003/004100 WO2003091194A1 (en) | 2002-04-23 | 2003-04-18 | Hyperforin derivatives, the use thereof and formulations containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60322871D1 true DE60322871D1 (en) | 2008-09-25 |
Family
ID=11449767
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60322871T Expired - Lifetime DE60322871D1 (en) | 2002-04-23 | 2003-04-18 | THINKING PREPARATIONS |
Country Status (19)
Country | Link |
---|---|
US (2) | US7105705B2 (en) |
EP (1) | EP1497250B1 (en) |
JP (1) | JP4315818B2 (en) |
KR (1) | KR100944052B1 (en) |
CN (1) | CN1290816C (en) |
AT (1) | ATE404519T1 (en) |
CA (1) | CA2483205C (en) |
DE (1) | DE60322871D1 (en) |
DK (1) | DK1497250T3 (en) |
ES (1) | ES2311697T3 (en) |
HK (1) | HK1075654A1 (en) |
IL (1) | IL164763A (en) |
IT (1) | ITMI20020872A1 (en) |
NO (1) | NO329176B1 (en) |
PL (1) | PL205829B1 (en) |
PT (1) | PT1497250E (en) |
RU (1) | RU2320636C2 (en) |
SI (1) | SI1497250T1 (en) |
WO (1) | WO2003091194A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102772461B (en) * | 2011-05-11 | 2014-05-14 | 成都康弘药业集团股份有限公司 | Application of medicament composition in preparing drug for preventing or treating senile dementia |
MX2013014162A (en) * | 2011-06-03 | 2014-09-08 | Harvard College | Hyperforin analogs, methods of synthesis, and uses thereof. |
ITMI20131012A1 (en) | 2013-06-19 | 2014-12-20 | Indena Spa | DERFORIN DERIVATIVES AND THEIR USE IN ALZHEIMER'S DISEASE |
US20180071269A1 (en) | 2015-08-12 | 2018-03-15 | Tianxin Wang | Therapeutical methods, formulations and nutraceutical formulations |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2162520T3 (en) | 1998-02-13 | 2001-12-16 | Schwabe Willmar Gmbh & Co | MEDICATIONS BASED ON HYPERFORINE AND / OR HYPERFORINE EXTRACTS. |
ATE253033T1 (en) | 1998-02-13 | 2003-11-15 | Schwabe Willmar Gmbh & Co | STABLE HYPERFORIN SALTS, METHOD FOR THE PRODUCTION THEREOF AND USE FOR THE THERAPY OF ALZHEIMER'S DISEASE |
IT1301679B1 (en) | 1998-06-10 | 2000-07-07 | Indena Spa | HYPERPHORINE DERIVATIVES, THEIR USE AND THE FORMULATIONS THAT CONTAIN IT. |
-
2002
- 2002-04-23 IT IT2002MI000872A patent/ITMI20020872A1/en unknown
-
2003
- 2003-04-18 WO PCT/EP2003/004100 patent/WO2003091194A1/en active IP Right Grant
- 2003-04-18 PL PL371347A patent/PL205829B1/en unknown
- 2003-04-18 RU RU2004131210/04A patent/RU2320636C2/en not_active IP Right Cessation
- 2003-04-18 CN CNB038089319A patent/CN1290816C/en not_active Expired - Fee Related
- 2003-04-18 AT AT03718778T patent/ATE404519T1/en active
- 2003-04-18 ES ES03718778T patent/ES2311697T3/en not_active Expired - Lifetime
- 2003-04-18 SI SI200331386T patent/SI1497250T1/en unknown
- 2003-04-18 JP JP2003587762A patent/JP4315818B2/en not_active Expired - Fee Related
- 2003-04-18 PT PT03718778T patent/PT1497250E/en unknown
- 2003-04-18 EP EP03718778A patent/EP1497250B1/en not_active Expired - Lifetime
- 2003-04-18 KR KR1020047016491A patent/KR100944052B1/en not_active IP Right Cessation
- 2003-04-18 DK DK03718778T patent/DK1497250T3/en active
- 2003-04-18 DE DE60322871T patent/DE60322871D1/en not_active Expired - Lifetime
- 2003-04-18 CA CA2483205A patent/CA2483205C/en not_active Expired - Fee Related
- 2003-04-18 US US10/512,067 patent/US7105705B2/en not_active Ceased
- 2003-04-18 US US12/896,158 patent/USRE43280E1/en not_active Expired - Fee Related
-
2004
- 2004-10-21 IL IL164763A patent/IL164763A/en not_active IP Right Cessation
- 2004-10-21 NO NO20044519A patent/NO329176B1/en not_active IP Right Cessation
-
2005
- 2005-09-05 HK HK05107783A patent/HK1075654A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PL205829B1 (en) | 2010-05-31 |
HK1075654A1 (en) | 2005-12-23 |
CA2483205C (en) | 2011-07-05 |
KR100944052B1 (en) | 2010-02-24 |
IL164763A (en) | 2010-02-17 |
AU2003222828A1 (en) | 2003-11-10 |
IL164763A0 (en) | 2005-12-18 |
PT1497250E (en) | 2008-11-12 |
ATE404519T1 (en) | 2008-08-15 |
EP1497250B1 (en) | 2008-08-13 |
DK1497250T3 (en) | 2008-12-01 |
USRE43280E1 (en) | 2012-03-27 |
JP4315818B2 (en) | 2009-08-19 |
CN1290816C (en) | 2006-12-20 |
ITMI20020872A1 (en) | 2003-10-23 |
CN1646462A (en) | 2005-07-27 |
WO2003091194A1 (en) | 2003-11-06 |
RU2320636C2 (en) | 2008-03-27 |
NO20044519L (en) | 2004-11-02 |
CA2483205A1 (en) | 2003-11-06 |
ES2311697T3 (en) | 2009-02-16 |
NO329176B1 (en) | 2010-09-06 |
EP1497250A1 (en) | 2005-01-19 |
ITMI20020872A0 (en) | 2002-04-23 |
US7105705B2 (en) | 2006-09-12 |
SI1497250T1 (en) | 2008-12-31 |
US20050165117A1 (en) | 2005-07-28 |
RU2004131210A (en) | 2005-04-10 |
PL371347A1 (en) | 2005-06-13 |
JP2005523917A (en) | 2005-08-11 |
KR20040111519A (en) | 2004-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002233288A1 (en) | Combined use of Enzyme Inhibitors and Pharmaceutical Preparations thereof for the Treatment and Prophylaxis of Arteriosclerosis, for the Treatment and Prevention of Allergic Reactions of Type I According to the Gell and Coombs Classification, and for the Treatment and Prevention of Dermatological Diseases Associated with FO | |
ATE309798T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABIDIOL DERIVATIVES | |
IL154888A (en) | Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis | |
DE60100866D1 (en) | Ophthalmic medicinal product containing cyclosporine, hyaluronic acid and polysorbate | |
BRPI0407662B8 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
DE60235719D1 (en) | WOMEN'S HYGIENIC PRODUCTS FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS | |
EP1578421A4 (en) | Pharmaceutical preparations for treatments of diseases and disorders of the breast | |
MX9605940A (en) | Bio-aromatic compounds carrying an adamantyl group in ortho, pharmaceutical and cosmetic compositions containing them and utilization. | |
MX9708800A (en) | Bicyclic-aromatic compounds. | |
ZA200501714B (en) | Analogues of vitamin d | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
JP2005511619A5 (en) | ||
GEP20063869B (en) | Novel cyclohexyl sulphones | |
HK1075654A1 (en) | Hyperforin derivatives, the use thereof and formulations containing them | |
MY130445A (en) | Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone | |
BR0116653A (en) | Medicinal product containing a polyamine as active substance | |
NO995838L (en) | New heteroethynylene compounds and pharmaceutical and cosmetic preparations containing the same | |
ITMI20021866A1 (en) | PHARMACEUTICAL PREPARATION IN COLLOIDAL FORM USEFUL IN THE TREATMENT OF SKIN DISEASES. | |
AR030945A1 (en) | AMIDAS OF FENILCICLOHEXANOCARBOXILICO SUBSTITUTED ACID AND USE | |
ATE241640T1 (en) | FUSIDIC ACID DERIVATIVES | |
HUP0204180A2 (en) | External composition and its use for treating of allergic skin diseases | |
ATE334675T1 (en) | MEDICINAL PRODUCTS CONTAINING SUBSTITUTED 2,5-DIAMINOMETHYL-1H-PYRROLES | |
IT1317818B1 (en) | PROCEDURE FOR THE PRODUCTION OF COMPONENTS FOR INTEGRATORIALIMENTARIES, DIETARY, COSMETIC AND PHARMACEUTICAL FORMULATIONS, | |
NO20033118L (en) | Micanolide derivatives, pharmaceutical preparations containing them and the use thereof for the manufacture of medicaments for the treatment of disease | |
UA37445A (en) | Anti-inflammatory drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8328 | Change in the person/name/address of the agent |
Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC |
|
8364 | No opposition during term of opposition |